Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

Approval Number

SIN17077P

Drug Name

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

Product Name

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

Approval Date

September 10, 2024

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

H05AA02

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PLIVA Croatia Ltd

Active Ingredients

Ingredient Name

Teriparatide

Strength

20 mcg/80 mcL

Drug MonographTeriparatide

Documents

Package Inserts

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN_PI.pdf

Approved: September 10, 2024

Patient Information Leaflets

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN_PIL.pdf

Approved: September 10, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy